Q: Any new thoughts on the prospects for VitalHub?
5i Research Answer:
There is not a lot 'new' here. We continue to like its prospects. It has received a couple of broker target price upgrades since its earnings, and has closed on its $75M financing. It thus has lots of cash now for growth opportunities, and EPS (consensus) is expected to more than double in 2026. It continues to look very good to us.